Clinical trials
Phase 3 Fatty Liver trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 3 |
| 2008 | 2 |
| 2009 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 6 |
| Terminated | 3 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 89bio, Inc. | 2 |
| GlaxoSmithKline | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| National Taiwan University Hospital | 2 |
| Sagimet Biosciences Inc. | 2 |
| Sanofi | 2 |
| Abbott | 1 |
| Assiut University | 1 |
| Bambino Gesù Hospital and Research Institute | 1 |
| Command Hospital, India | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fatty Liver | 25 |
| Non-alcoholic Fatty Liver Disease | 20 |
| Fibrosis | 7 |
| Liver Diseases | 4 |
| Obesity | 3 |
| Diabetes Mellitus | 2 |
| Digestive System Diseases | 2 |
| Insulin Resistance | 2 |
| Liver Cirrhosis | 2 |
| Metabolic Diseases | 2 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.